Correlation Between Esperion Therapeutics and CalciMedica, Common
Can any of the company-specific risk be diversified away by investing in both Esperion Therapeutics and CalciMedica, Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Esperion Therapeutics and CalciMedica, Common into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Esperion Therapeutics and CalciMedica, Common Stock, you can compare the effects of market volatilities on Esperion Therapeutics and CalciMedica, Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Esperion Therapeutics with a short position of CalciMedica, Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Esperion Therapeutics and CalciMedica, Common.
Diversification Opportunities for Esperion Therapeutics and CalciMedica, Common
-0.74 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Esperion and CalciMedica, is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Esperion Therapeutics and CalciMedica, Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CalciMedica, Common Stock and Esperion Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Esperion Therapeutics are associated (or correlated) with CalciMedica, Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CalciMedica, Common Stock has no effect on the direction of Esperion Therapeutics i.e., Esperion Therapeutics and CalciMedica, Common go up and down completely randomly.
Pair Corralation between Esperion Therapeutics and CalciMedica, Common
Given the investment horizon of 90 days Esperion Therapeutics is expected to generate 0.89 times more return on investment than CalciMedica, Common. However, Esperion Therapeutics is 1.12 times less risky than CalciMedica, Common. It trades about 0.09 of its potential returns per unit of risk. CalciMedica, Common Stock is currently generating about 0.05 per unit of risk. If you would invest 76.00 in Esperion Therapeutics on September 19, 2024 and sell it today you would earn a total of 140.00 from holding Esperion Therapeutics or generate 184.21% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Esperion Therapeutics vs. CalciMedica, Common Stock
Performance |
| Timeline |
| Esperion Therapeutics |
| CalciMedica, Common Stock |
Esperion Therapeutics and CalciMedica, Common Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Esperion Therapeutics and CalciMedica, Common
The main advantage of trading using opposite Esperion Therapeutics and CalciMedica, Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Esperion Therapeutics position performs unexpectedly, CalciMedica, Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CalciMedica, Common will offset losses from the drop in CalciMedica, Common's long position.| Esperion Therapeutics vs. Elanco Animal Health | Esperion Therapeutics vs. SIGA Technologies | Esperion Therapeutics vs. Catalent | Esperion Therapeutics vs. ANI Pharmaceuticals |
| CalciMedica, Common vs. Digi International | CalciMedica, Common vs. Lipocine | CalciMedica, Common vs. Asure Software | CalciMedica, Common vs. Perseus Mining Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |